Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function.
暂无分享,去创建一个
C. Singer | H. Smith | H. Lynch | M. Lippman | A. Rasmussen | K. Cullen | Marc E. Lippman | Kevin J. Cullen | Christian Singer | Helene S. Smith | Henry T. Lynch
[1] P. Houghton,et al. Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma. , 1994, The Journal of clinical investigation.
[2] D. Coppola,et al. Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts , 1994, Molecular and cellular biology.
[3] N. Ling,et al. Hormonal regulation of insulin-like growth factor II and insulin-like growth factor binding protein expression by breast cancer cells in vivo: evidence for stromal epithelial interactions. , 1994, Cancer research.
[4] M. Miura,et al. Platelet-derived growth factor-induced expression of messenger RNA for the proliferating cell nuclear antigen requires a functional receptor for the insulin-like growth factor I. , 1994, Cancer research.
[5] D. Coppola,et al. Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors. , 1994, Cancer research.
[6] C. Mainguené,et al. Fibroblast‐mediated differentiation in human breast carcinoma cells (MCF‐7) grown as nodules IN VITRO , 1994, International journal of cancer.
[7] D. Brouty‐boye,et al. Myofibroblast and concurrent ED-B fibronectin phenotype in human stromal cells cultured from non-malignant and malignant breast tissue. , 1994, European journal of cancer.
[8] J. Baker,et al. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) , 1993, Cell.
[9] K. Horgan,et al. Fibroblast stimulation of breast cancer cell growth in a serum-free system. , 1993, British Journal of Cancer.
[10] Donna M. Martin,et al. Regulation of insulin‐like growth factor‐II expression and its role in autocrine growth of human neuroblastoma cells , 1993 .
[11] M. Loriot,et al. Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[12] M. Tykocinski,et al. Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. , 1993, Science.
[13] Wei-Hua Lee,et al. Mapping of brain insulin and insulin-like growth factor receptor gene expression by in situ hybridization , 1992 .
[14] W. Ruan,et al. Intact and amino-terminally shortened forms of insulin-like growth factor I induce mammary gland differentiation and development. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[15] A. Ullrich,et al. Roles of insulinlike growth factor 1 (IGF-1) and the IGF-1 receptor in epidermal growth factor-stimulated growth of 3T3 cells , 1992, Molecular and cellular biology.
[16] A. Ullrich,et al. Constitutive expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor abrogates all requirements for exogenous growth factors. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[17] V. Macaulay,et al. Insulin-like growth factors and cancer. , 1992, British Journal of Cancer.
[18] K J Cullen,et al. Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression. , 1992, Molecular endocrinology.
[19] M. Lippman,et al. Stromal-epithelial interactions in breast cancer. , 1992, Cancer treatment and research.
[20] N. Rosen,et al. Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions. , 1991, Cancer research.
[21] R. Daly,et al. Autocrine production of insulin-like growth factor II using an inducible expression system results in reduced estrogen sensitivity of MCF-7 human breast cancer cells. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[22] A. Efstratiadis,et al. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting , 1990, Nature.
[23] C. Osborne,et al. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. , 1989, Molecular endocrinology.
[24] D. Hanahan,et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.
[25] A. Schor,et al. Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[26] D. Yee,et al. Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer. , 1989, Molecular endocrinology.
[27] D. Yee,et al. Insulin-like growth factor II mRNA expression in human breast cancer. , 1988, Cancer research.
[28] A. Schor,et al. Foetal and cancer patient fibroblasts produce an autocrine migration-stimulating factor not made by normal adult cells. , 1988, Journal of cell science.
[29] C. Heldin,et al. Frequent expression of growth factors for mesenchymal cells in human mammary carcinoma cell lines. , 1987, Cancer research.
[30] R. Mansel,et al. Mitogenicity of human fibroblasts in vivo for human breast cancer cells , 1987, The British journal of surgery.
[31] A. Schor,et al. Skin fibroblasts obtained from cancer patients display foetal-like migratory behaviour on collagen gels. , 1985, Journal of cell science.
[32] R. Shiu,et al. Receptor binding and growth-promoting activity of insulin-like growth factors in human breast cancer cells (T-47D) in culture. , 1984, Cancer research.
[33] C. Chaponnier,et al. Abnormal properties of skin fibroblasts from patients with breast cancer , 1984, International journal of cancer.
[34] R. Furlanetto,et al. Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture. , 1984, Cancer research.
[35] W. Rutter,et al. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.